Inventor · Sunnyvale, CA, US

Sreenivas Punna

66Patents
11h-index
47Co-inventors
74Inventor score

Filing activity: Jul 14, 2006 → Sep 13, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7622583B2 Heteroaryl sulfonamides and CCR2 Chemistry; Metallurgy 92 Active
US7884110B2 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation Chemistry; Metallurgy 33 Active
US7718683B2 Triazolyl phenyl benzenesulfonamides Chemistry; Metallurgy 33 Active
US8445518B2 Triazolyl pyridyl benzenesulfonamides Human Necessities 21 Active
US8546408B2 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation Chemistry; Metallurgy 17 Active
US8093247B2 Heteroaryl sulfonamides and CCR2 Chemistry; Metallurgy 15 Active
US10639284B2 Immunomodulator compounds Emerging Cross-Sectional Technologies 13 Active
US9745312B2 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation Chemistry; Metallurgy 13 Active
US9394307B2 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation Chemistry; Metallurgy 13 Active
US10919852B2 Immunomodulator compounds Emerging Cross-Sectional Technologies 12 Active
US10392405B2 Macrocyclic immunomodulators Chemistry; Metallurgy 11 Active
US10568874B2 Indane-amines as PD-L1 antagonists Emerging Cross-Sectional Technologies 11 Active
US10329314B2 Soluble C5aR antagonists Chemistry; Metallurgy 11 Active
US11059834B2 Macrocyclic immunomodulators Chemistry; Metallurgy 8 Active
US7776877B2 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides Chemistry; Metallurgy 8 Active
US11266643B2 Triaryl compounds for treatment of PD-L1 diseases Chemistry; Metallurgy 8 Active
US10562896B2 6-5 fused rings as C5a inhibitors Chemistry; Metallurgy 8 Active
US9745268B2 Processes and intermediates in the preparation of C5aR antagonists Human Necessities 8 Active
US11135210B2 Indane-amines as PD-L1 antagonists Emerging Cross-Sectional Technologies 8 Active
US10759807B2 Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors Human Necessities 7 Active
US10683294B2 5-5 fused rings as C5a inhibitors Human Necessities 7 Active
US8835419B2 Substituted anilines as CCR(4) antagonists Chemistry; Metallurgy 7 Active
US11426364B2 Immunomodulator compounds Emerging Cross-Sectional Technologies 7 Active
US10266492B2 Processes and intermediates in the preparation of C5aR antagonists Human Necessities 6 Active
US7683176B2 Triazolyl pyridyl benzenesulfonamides Human Necessities 6 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.